Cancer immunotherapy company MabVax Therapeutics and Telik, a clinical stage oncology drug development company have entered into a definitive merger agreement. MabVax is backed by Numoda Capital Innovations, Burrill Capital and RTP Venture Fund.
7 min read · 13 May 2014
GI Partners has acquired IT infrastructure and cloud provider, Peak 10 from Welsh, Carson, Anderson & Stowe. Headquartered in Charlotte, N.C., the business provides hybrid IT infrastructure services including data center services, private and enterprise cloud infrastructure, and managed services.
3 min read · 13 May 2014
Planning platform business Anaplan has completed a Series D round of $100 million in financing, bringing total investment in the company to $150 million. The round was led by DFJ Growth with participation from Brookside Capital, Coatue Management, Sands Capital Management, and Workday and Anaplan’s current investors, Granite Ventures, Meritech Capital Partners, salesforce.com, and Shasta Ventures.
3 min read · 13 May 2014
This morning there is private equity related pension news aplenty with links to whether New York pensions are investing enough in the asset class, CalPERs considering reducing its allocation target and yet also recruiting for a senior private equity portfolio manager.
1 min read · 13 May 2014
This week there are analyst, associate and senior portfolio manager positions up for grabs at The Blackstone Group, Goldman Sachs, San Francisco Employees' Retirement System and Ziegler.
2 min read · 12 May 2014
Genstar Capital Management has sold portfolio company TravelClick to Thoma Bravo for $930 million. Thoma Bravo is a provider of cloud-based software solutions to the hospitality industry.
2 min read · 12 May 2014
Accord Group Holdings has received a preferred equity investment from JMP Group, an investment banking and alternative asset management firm. Terms of the financing were not disclosed. Accord is a provider of investment management and advisory services to the real estate private equity industry.
3 min read · 12 May 2014
Chase Pharmaceuticals Corporation has raised a $21 million Series B financing led by New Rhein Healthcare Investors. Other new investors include Edmond de Rothschild Investment Partners and Cipla Ventures, the new venture capital arm of Cipla Pharmaceuticals.
5 min read · 12 May 2014
Huron Capital Partners has backed Valentus Specialty Chemicals with industry veteran Ray Chlodney. The business operates in the specialty coatings industry.
3 min read · 12 May 2014
Yarmouth Venture Group has opened a North Carolina office. Established in 1999, Yarmouth Venture Group is an investment and advisory firm.
1 min read · 12 May 2014
